FDA Inspection
Vitane Pharmaceutical, Inc.Vitane Pharmaceutical, Inc. – FDA Inspection, Oct 23, 2024
Record Details
This FDA Inspection record concerns Vitane Pharmaceutical, Inc., with an inspection on October 23, 2024, issued by the New York District Office, covering human drugs.
View Company Profile
ID · 133cbd3f-c551-4a74-b323-55c34ef10345
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1252374
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.142(b)Storage under appropriate conditions
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.180(e)Records reviewed annually
- 21 CFR 211.84(d)(2)Reports of Analysis (Components)
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitane Pharmaceutical, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 21, 2024 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
Other documents for Vitane Pharmaceutical, Inc.
- FDA Inspection 1235772 - 2024-03-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.